Short Interest in Aspira Women’s Health Inc. (NASDAQ:AWH) Rises By 10.9%

Aspira Women’s Health Inc. (NASDAQ:AWH) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 439,200 shares, an increase of 10.9% from the January 15th total of 396,200 shares. Based on an average daily trading volume, of 97,900 shares, the short-interest ratio is currently 4.5 days. Approximately 3.6% of the company’s stock are sold short.

Aspira Women’s Health Price Performance

NASDAQ:AWH traded down $0.04 during mid-day trading on Friday, reaching $0.24. The company’s stock had a trading volume of 907,741 shares, compared to its average volume of 106,812. Aspira Women’s Health has a 12-month low of $0.20 and a 12-month high of $5.00. The firm’s fifty day moving average price is $0.57 and its two-hundred day moving average price is $0.79.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Aspira Women’s Health in a research note on Sunday, January 12th. They issued a “hold” rating on the stock.

Institutional Trading of Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. increased its position in Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the period. B. Riley Wealth Advisors Inc. owned about 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 12.19% of the company’s stock.

About Aspira Women’s Health

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.